{"id":"W3116445431","doi":"10.3747/co.27.6795","title":"Bruton Tyrosine Kinase Inhibitors for the Frontline Treatment of Chronic Lymphocytic Leukemia","year":2020,"lang":"en","type":"review","venue":"Current Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Impact; Fluidigm (Canada); Dalhousie University; Research Institute in Oncology and Hematology; University of Ottawa; BC Cancer Agency; University of Manitoba; Canadian Blood Services; CancerCare Manitoba","funders":"","keywords":"Bruton's tyrosine kinase; Chemoimmunotherapy; Chronic lymphocytic leukemia; Medicine; Ibrutinib; Tyrosine kinase; Venetoclax; Clinical trial; Oncology; Immunology; Leukemia; Cancer research; Internal medicine; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004874711,0.0005112803,0.0008228022,0.001847282,0.0002279322,0.0006384818,0.0007245544,0.0006605001,0.004899636],"category_scores_gemma":[0.000661665,0.0001573792,0.000489951,0.00164698,0.000267678,0.0007150229,0.0004450183,0.001512398,0.00233275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008071263,"about_ca_system_score_gemma":0.001351092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002214544,"about_ca_topic_score_gemma":0.007122028,"domain_scores_codex":[0.9998289,0.00002592019,0.00002012984,0.00002017473,0.0000841339,0.00002070955],"domain_scores_gemma":[0.9997606,0.0000929848,0.00003375435,0.000005489958,0.00007773084,0.00002957446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00007102535,0.00003935124,0.0001094019,0.01299507,0.00007500892,0.0001096239,0.00004248623,0.0002411262,0.001076221,0.002769572,0.06428698,0.9181842],"study_design_scores_gemma":[0.00001812237,0.00004743122,0.0004290803,0.002616674,0.0000663703,0.0004155152,0.00002148074,0.00002990043,0.0001313463,0.0006911457,0.9955261,0.000006727953],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001011463,0.9976089,0.00006428079,0.0003258961,0.0002610284,0.000005656345,0.00002925918,0.000008623187,0.001595179],"genre_scores_gemma":[0.0005238351,0.9982132,0.00009844406,0.000265912,0.0001035975,0.000004279891,0.0000444923,0.000001246256,0.0007450404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004899636,"threshold_uncertainty_score":0.01639098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1956499198963031,"score_gpt":0.4712094648633718,"score_spread":0.2755595449670687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}